Radioiodine in Low-Risk Thyroid Cancer | NEJM
1 Views
administrator
07/06/23
Radioiodine is typically administered after thyroidectomy in patients with thyroid cancer, but its benefits in those with low-risk disease are controversial. New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3HvClQD
-
Category
Show more
Facebook Comments
No comments found